CoChat

Mechanisms of Amyloid Deposition in Alzheimer's Diseasea

BEYREUTHER, KONRAD, BUSH, ASHLEY I., DYRKS, THOMAS, HILBICH, CAROLINE, KöNIG, GERHARD, MöNNING, URSULA, MULTHAUP, GERD, PRIOR, REINHARD, RUMBLE, BADEN, SCHUBERT, WALTER, SMALL, DAVID H., WEIDEMANN, ANDREAS, MASTERS, COLIN L. · 1991 · Annals of the New York Academy of Sciences
Cited by 64

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

At the cellular level, Alzheimer's disease (AD) must be the result of neuronal dysfunction and degeneration leading to a reduction in synaptic density. Filamentous deposits of amyloid, which define the disease at the molecular level, occur within perikarya, axons, dendrites, and terminals of neurons as neurofibrillary tangles (NFT), in the extracellular neuropil as amyloid plaques (APC), and around blood vessels as amyloid congophilic angiopathy (ACA). These fibrillar amyloid protein aggregates are also found in the brain of all individuals with Down's syndrome after the age of 30 years. The amyloid deposits apparently occur in the terminal zones of neurons that develop NFT. It is suggested that amyloid deposition is of fundamental significance in AD and that a thorough understanding of amyloid formation will eventually lead to successful therapeutic intervention in AD. As elucidation of the reasons behind amyloid deposition must shed some light on the pathogenesis of AD, we review the current state of knowledge on the nature of the AD amyloid protein, its origin, and its formation. Although there is yet no agreement about the chemical nature of the amyloid protein of NFT, the major constituent of both APC and ACA has been shown to be a 4.5-kD amyloid protein originally termed "beta-protein" or "amyloid A4" which we now denote as "beta A4." Amyloid beta A4 protein is proteolytically derived from a transmembrane protein termed amyloid precursor protein (APP) which is encoded by a widely expressed gene on chromosome 21. Our present results are consistent with the possibility that amyloid formation requires membrane damage or APP molecules that are not or are incorrectly integrated into membranes. To allow the generation of the C-terminus of beta A4, one proteolytic cleavage step has to occur in the sequence that normally forms the transmembrane domain of the APP proteins. This cleavage is crucial for amyloid formation because we could show that the ability of synthetic beta A4 to form amyloid depositions is mainly based on hydrophobic parts of the sequence that have to interact with each other and build up large aggregates under physiologic conditions. Membrane association of APP is expected to interfere with this cleavage and the process of aggregation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.1991.tb00204.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 64

Metadata

Authors
BEYREUTHER, K., BUSH, A. I., DYRKS, T., HILBICH, C., KöNIG, G., MöNNING, U., MULTHAUP, G., PRIOR, R., RUMBLE, B., SCHUBERT, W., SMALL, D. H., WEIDEMANN, A., & MASTERS, C. L.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
1991-12
Volume
640
Issue
1
Pages
129-139
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2414788290
Cited by
64
References
3
FWCI
2.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Amyloid Deposition in Alzheimer's Diseasea. https://app.cochat.ai/papers/10.1111/j.1749-6632.1991.tb00204.x
The paper
BEYREUTHER, K., BUSH, A. I., DYRKS, T., HILBICH, C., KöNIG, G., MöNNING, U., MULTHAUP, G., PRIOR, R., RUMBLE, B., SCHUBERT, W., SMALL, D. H., WEIDEMANN, A., & MASTERS, C. L. (1991). Mechanisms of Amyloid Deposition in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1991.tb00204.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.